| Financial Year |
March 31 2023 |
| Monetary Funds |
490,766,077.85 |
| Held-for-trading Financial Assets |
271,917,039.83 |
| Notes Receivable |
775,369,918.72 |
| Accounts Receivable |
777,572,485.75 |
| Advances to Suppliers |
93,638,591.52 |
| Other Receivables |
8,650,639.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
569,742,479.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
106,021,071.07 |
| Total Current Assets |
3,173,638,784.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
128,747,446.37 |
| Investment Properties |
736,338.61 |
| Fixed Assetes |
782,947,142.36 |
| Under-construction Projects |
420,236,491.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
205,315,787.33 |
| R&D expenses |
-- |
| Goodwill |
40,241,547.46 |
| Long-Term Deferred and Prepaid Expenses |
11,263,178.30 |
| Deferred Income Tax Assets |
24,351,387.55 |
| Other Non-Current Assets |
40,151,904.18 |
| Sub-Total of Non-Current Assets |
1,670,603,203.73 |
| Total Assets |
4,844,241,987.78 |
| Short-Term Loans |
313,856,933.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
285,758,371.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,927,072.33 |
| Taxes Payable |
12,987,441.40 |
| Interest Payable |
558,304.38 |
| Dividend Payable |
-- |
| Other payables |
24,124,092.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,418,218.65 |
| Other Current Liabilities |
505,984,918.05 |
| Sub-Total of Current Liabilities |
1,196,896,824.48 |
| Long-term Loans |
30,032,083.33 |
| Bonds Payable |
308,302,573.88 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,384,068.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
456,554,982.87 |
| Total Liabilities |
1,653,451,807.35 |
| Paid-In Capital(Or Share Stock) |
447,811,056.00 |
| Capital Surplus |
845,158,755.97 |
| Surplus Reserve |
176,134,443.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,469,696,347.23 |
| Minority Stockholder's Interest |
155,431,006.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,035,359,174.33 |
| Owner's Equity（Stockholder's Equity） |
3,190,790,180.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,844,241,987.78 |
